We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
-3.68%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$44.3B
AUM Growth
-$9.51B
(-18%)
Cap. Flow
-$5.7B
Cap. Flow
% of AUM
-12.89%
Top 10 Holdings %
Top 10 Hldgs %
12.78%
Holding
2,408
New
212
Increased
800
Reduced
967
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$160M |
| 2 |
S&P Global
SPGI
|
+$159M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$123M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$111M |
| 5 |
Pfizer
PFE
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$1.01B |
| 2 |
NBIS
Nebius Group N.V.
NBIS
|
+$257M |
| 3 |
Chevron
CVX
|
+$236M |
| 4 |
ExxonMobil
XOM
|
+$224M |
| 5 |
AbbVie
ABBV
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.63% |
| 2 | Technology | 17.13% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 8.9% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.9T
| $746M | 1.68% |
2,418,607
+22,964
| +1% | +$6.91M |
|
2
Apple
AAPL
$5T
| $712M | 1.61% |
4,079,912
+2,509
| +0.1% | +$422K |
|
|
3
AbbVie
ABBV
$469B
| $632M | 1.43% |
3,900,939
-1,264,452
| -24% | -$184M |
|
|
4
Chevron
CVX
$384B
| $599M | 1.35% |
3,678,173
-1,645,751
| -31% | -$236M |
|
5
Alphabet (Google) Class A
GOOGL
$4.1T
| $582M | 1.31% |
4,183,580
-296,360
| -7% | -$40.3M |
|
|
6
ExxonMobil
XOM
$652B
| $516M | 1.17% |
6,253,447
-2,884,230
| -32% | -$224M |
|
7
Philip Morris
PM
$311B
| $479M | 1.08% |
5,100,156
-201,769
| -4% | -$20.2M |
|
8
Amazon
AMZN
$2.47T
| $473M | 1.07% |
2,901,100
-329,460
| -10% | -$50.9M |
|
9
Verizon
VZ
$201B
| $464M | 1.05% |
9,114,174
+696,744
| +8% | +$36.9M |
|
10
Merck
MRK
$325B
| $452M | 1.02% |
5,509,801
-633,910
| -10% | -$50M |
|
11
Gilead Sciences
GILD
$166B
| $414M | 0.94% |
6,966,697
+588,734
| +9% | +$37.6M |
|
12
Southern Company
SO
$109B
| $399M | 0.9% |
5,502,146
-1,059,691
| -16% | -$71.8M |
|
|
13
Bristol-Myers Squibb
BMY
$130B
| $371M | 0.84% |
5,077,139
+1,839,065
| +57% | +$123M |
|
14
Amgen
AMGN
$213B
| $359M | 0.81% |
1,484,974
-58,433
| -4% | -$13.4M |
|
15
Duke Energy
DUK
$101B
| $351M | 0.79% |
3,140,290
-1,612,437
| -34% | -$167M |
|
|
16
Pfizer
PFE
$144B
| $344M | 0.78% |
6,643,171
+2,091,343
| +46% | +$109M |
|
17
DexCom
DXCM
$28.7B
| $318M | 0.72% |
2,484,540
-688
| -0% | -$75.3K |
|
18
Credicorp
BAP
$30.9B
| $315M | 0.71% |
1,831,071
+41
| +0% | +$6.19K |
|
19
Dominion Energy
D
$62.7B
| $314M | 0.71% |
3,699,653
-303,074
| -8% | -$24.3M |
|
20
General Mills
GIS
$20.1B
| $305M | 0.69% |
4,497,372
-467,231
| -9% | -$31.3M |
|
21
Ultragenyx Pharmaceutical
RARE
$2.58B
| $290M | 0.65% |
3,987,728
+858
| +0% | +$59.7K |
|
22
ServiceNow
NOW
$113B
| $274M | 0.62% |
2,464,575
-85,525
| -3% | -$9.58M |
|
23
Huntington Bancshares
HBAN
$34.9B
| $268M | 0.61% |
18,352,191
+3,149,952
| +21% | +$49.3M |
|
24
AT&T
T
$168B
| $267M | 0.6% |
14,983,347
+2,715,874
| +22% | +$50.2M |
|
25
Trane Technologies
TT
$103B
| $259M | 0.58% |
1,694,649
-65,848
| -4% | -$10.8M |
|
Similar funds
Federated Hermes's Q1 2022 Portfolio in Review
As of Q1 2022, Federated Hermes held 2,408 positions worth $44.3B, down 18% from $53.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes withdrew a net $5.7B in Q1 2022, closing 238 positions and reducing 967 holdings. Its most notable exit was Nebius Group N.V., an estimated $257M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
Against the trend, Federated Hermes opened a new position in Apollo Global Management worth $44.5M.
- Federated Hermes's largest Q1 2022 buy was Apollo Global Management: 718,400 shares worth $44.5M.
- Federated Hermes added most to Clorox in Q1 2022, an estimated $160M increase.
- Federated Hermes's biggest Q1 2022 reduction was TSMC, cutting an estimated $1.01B.
- Federated Hermes fully exited Nebius Group N.V. in Q1 2022, selling an estimated $257M.
- Federated Hermes's ten largest holdings make up 13% of its $44.3B portfolio in Q1 2022.
- Federated Hermes opened 212 new positions and closed 238 in Q1 2022.
- Federated Hermes's portfolio value fell 18% quarter-over-quarter to $44.3B.
Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.